Patents by Inventor Michael Desjardin

Michael Desjardin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140171505
    Abstract: Provided herein are pharmaceutical compositions and formulations comprising mixed salts of gamma-hydroxybutyrate (GHB). Also provided herein are methods of making the pharmaceutical compositions and formulations, and methods of their use for the treatment of sleep disorders such as apnea, sleep time disturbances, narcolepsy, cataplexy, sleep paralysis, hypnagogic hallucination, sleep arousal, insomnia, and nocturnal myoclonus.
    Type: Application
    Filed: October 3, 2013
    Publication date: June 19, 2014
    Applicant: Jazz Pharmaceuticals, Inc.
    Inventors: Clark P. Allphin, Michael DesJardin
  • Publication number: 20140171506
    Abstract: Provided herein are pharmaceutical compositions and formulations comprising mixed salts of gamma-hydroxybutyrate (GHB). Also provided herein are methods of making the pharmaceutical compositions and formulations, and methods of their use for the treatment of sleep disorders such as apnea, sleep time disturbances, narcolepsy, cataplexy, sleep paralysis, hypnagogic hallucination, sleep arousal, insomnia, and nocturnal myoclonus.
    Type: Application
    Filed: February 4, 2014
    Publication date: June 19, 2014
    Applicant: Jazz Pharmaceuticals, Inc.
    Inventors: Clark P. Allphin, Michael DesJardin
  • Publication number: 20140088013
    Abstract: Formulations and methods are provided for improving the stability upon exposure to aqueous media of polypeptides present in non-aqueous suspension vehicles. In particular aspects of the invention, formulations are provided that comprise a complex of a metal ion and a polypeptide suspended in a non-aqueous, biocompatible suspension vehicle. Aggregation of individual polypeptide molecules is reduced when aqueous media is introduced to such formulations, serving to stabilize the polypeptide.
    Type: Application
    Filed: March 7, 2013
    Publication date: March 27, 2014
    Inventors: Catherine M. Rohloff, Guohua Chen, Zhongli Ding, Stephen A. Berry, Latha P. Narayanan, Michael A. Desjardin
  • Patent number: 8591922
    Abstract: Provided herein are pharmaceutical compositions and formulations comprising mixed salts of gamma-hydroxybutyrate (GHB). Also provided herein are methods of making the pharmaceutical compositions and formulations, and methods of their use for the treatment of sleep disorders such as apnea, sleep time disturbances, narcolepsy, cataplexy, sleep paralysis, hypnagogic hallucination, sleep arousal, insomnia, and nocturnal myoclonus.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: November 26, 2013
    Assignee: Jazz Pharmacuticals, Inc.
    Inventors: Clark P. Allphin, Michael DesJardin
  • Patent number: 8544439
    Abstract: An engine air intake tract includes a flexible air intake duct having a flexible tubular body. A plurality of radially extending convolutes are formed in and spaced apart on an axially extending outer wall of the tubular body. Each convolute has a circumferential ring-shaped inwardly extending peak bordered by outwardly extending troughs. A liquid sump is formed into a lower portion of the tubular body and includes a plurality of spaced sump chambers with each chamber formed between and connected to at least two adjacent ones of the convolutes and extending radially outwardly from the convolutes.
    Type: Grant
    Filed: June 21, 2011
    Date of Patent: October 1, 2013
    Assignee: Mann & Hummel GmbH
    Inventor: Michael Desjardins
  • Publication number: 20130247376
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Application
    Filed: May 20, 2013
    Publication date: September 26, 2013
    Applicant: INTARCIA THERAPEUTICS, INC.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • Publication number: 20130251674
    Abstract: The present invention is related to materials and methods for forming polymeric delivery vehicles that reduces risk of oxidative degradation of a carried drug and the resulting compositions.
    Type: Application
    Filed: January 31, 2013
    Publication date: September 26, 2013
    Inventors: Pamela J. Fereira, Michael Desjardin, Catherine M. Rohloff, Stephen A. Berry, Ekaterina S. Zlatkova-Karaslavova
  • Patent number: 8496943
    Abstract: The present invention is related to materials and methods for forming polymeric delivery vehicles that reduces risk of oxidative degradation of a carried drug and the resulting compositions.
    Type: Grant
    Filed: July 18, 2005
    Date of Patent: July 30, 2013
    Assignee: Durect Corporation
    Inventors: Pamela J. Fereira, Michael A. Desjardin, Catherine M. Rohloff, Stephen A. Berry, Ekaterina S. Zlatkova-Karaslavova
  • Publication number: 20130181674
    Abstract: There is described an electric vehicle charging station for charging an electric vehicle, comprising: an electrical connector electrically connectable to a source of electrical energy, the electrical connector adapted for connecting to a battery of the electric vehicle; a frame having a connector receiving portion for receiving the electrical connector; a locking unit mounted to the frame for preventing a user access to the electrical connector; and a control unit operatively connected to the locking unit, the control unit for verifying rights of a user to access the electrical connector and unlocking the locking unit upon successful verification of the user rights to provide the user access to the electrical connector.
    Type: Application
    Filed: September 12, 2011
    Publication date: July 18, 2013
    Inventors: Louis Tremblay, Michael Desjardins
  • Publication number: 20130167490
    Abstract: A filter assembly may include a housing, a filter element, and a layer of air-permeable material. The housing may include an inlet and an outlet. The filter element may be disposed within the housing and may include an upstream face, a downstream face, a first end face facing the inlet and extending between the upstream and downstream faces. The layer of air-permeable material may be attached to the filter element and may cover the upstream face and a portion of the first end face that is exposed to the inlet.
    Type: Application
    Filed: January 3, 2012
    Publication date: July 4, 2013
    Applicant: MANN+HUMMEL GMBH
    Inventors: Joshua J. Barron, Alexander Braithwaite, Michael Desjardins
  • Publication number: 20130169227
    Abstract: A modular charging station for charging an electric vehicle, the modular charging station comprising: a frame having a receiving portion; a control unit removably secured to the receiving portion of the frame and electrically connectable to a source of electrical energy, the control unit for selectively controlling access to the electrical energy; and a distributing unit removably secured to the frame, electrically connected to the control unit for receiving the electrical energy therefrom, and electrically connectable to the electric vehicle for providing the electrical energy to the electric vehicle, a powering of the distributing unit being controlled by the control unit.
    Type: Application
    Filed: September 13, 2011
    Publication date: July 4, 2013
    Inventors: Louis Tremblay, Michael Desjardins
  • Patent number: 8470353
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Grant
    Filed: January 12, 2013
    Date of Patent: June 25, 2013
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • Patent number: 8460694
    Abstract: A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be selected from the group consisting of benzyl benzoate, decanol, ethyl hexyl lactate, and mixtures thereof and the at least one polymer may be selected from the group consisting of a polyester, pyrrolidone, ester of an unsaturated alcohol, ether of an unsaturated alcohol, polyoxyethylenepolyoxypropylene block copolymer, and mixtures thereof. In one embodiment, the at least one solvent is benzyl benzoate and the at least one polymer is polyvinylpyrrolidone. A stable, nonaqueous suspension formulation that includes the nonaqueous, single-phase vehicle and an active agent, and a method of forming the same, are also disclosed.
    Type: Grant
    Filed: October 8, 2012
    Date of Patent: June 11, 2013
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Catherine M. Rohloff, Guohua Chen, Andrew S. Luk, Rupal A. Ayer, Paul R. Houston, Michael A. Desjardin, Pauline Zamora, Stan Lam
  • Publication number: 20130138089
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Application
    Filed: January 12, 2013
    Publication date: May 30, 2013
    Applicant: INTARCIA THERAPEUTICS, INC.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • Patent number: 8440226
    Abstract: A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be selected from the group consisting of benzyl benzoate, decanol, ethyl hexyl lactate, and mixtures thereof and the at least one polymer may be selected from the group consisting of a polyester, pyrrolidone, ester of an unsaturated alcohol, ether of an unsaturated alcohol, polyoxyethylenepolyoxypropylene block copolymer, and mixtures thereof. In one embodiment, the at least one solvent is benzyl benzoate and the at least one polymer is polyvinylpyrrolidone. A stable, nonaqueous suspension formulation that includes the nonaqueous, single-phase vehicle and an active agent, and a method of forming the same, are also disclosed.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: May 14, 2013
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Catherine M. Rohloff, Guohua Chen, Andrew S. Luk, Rupal A. Ayer, Paul R. Houston, Michael A. Desjardin, Pauline Zamora, Stan Lam
  • Publication number: 20130034210
    Abstract: A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be selected from the group consisting of benzyl benzoate, decanol, ethyl hexyl lactate, and mixtures thereof and the at least one polymer may be selected from the group consisting of a polyester, pyrrolidone, ester of an unsaturated alcohol, ether of an unsaturated alcohol, polyoxyethylenepolyoxypropylene block copolymer, and mixtures thereof. In one embodiment, the at least one solvent is benzyl benzoate and the at least one polymer is polyvinylpyrrolidone. A stable, nonaqueous suspension formulation that includes the nonaqueous, single-phase vehicle and an active agent, and a method of forming the same, are also disclosed.
    Type: Application
    Filed: October 9, 2012
    Publication date: February 7, 2013
    Applicant: Intarcia Therapeutics, Inc.
    Inventors: Catherine M. Rohloff, Guohua Chen, Andrew S. Luk, Rupal A. Ayer, Paul R. Houston, Michael A. Desjardin, Pauline Zamora, Stan Lam
  • Publication number: 20130035670
    Abstract: A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be selected from the group consisting of benzyl benzoate, decanol, ethyl hexyl lactate, and mixtures thereof and the at least one polymer may be selected from the group consisting of a polyester, pyrrolidone, ester of an unsaturated alcohol, ether of an unsaturated alcohol, polyoxyethylenepolyoxypropylene block copolymer, and mixtures thereof. In one embodiment, the at least one solvent is benzyl benzoate and the at least one polymer is polyvinylpyrrolidone. A stable, nonaqueous suspension formulation that includes the nonaqueous, single-phase vehicle and an active agent, and a method of forming the same, are also disclosed.
    Type: Application
    Filed: October 8, 2012
    Publication date: February 7, 2013
    Applicant: INTARCIA THERAPEUTICS, INC.
    Inventors: Catherine M. Rohloff, Guohua Chen, Andrew S. Luk, Rupal A. Ayer, Paul R. Houston, Michael A. Desjardin, Pauline Zamora, Stan Lam
  • Patent number: 8367095
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: February 5, 2013
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • Publication number: 20120330282
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Application
    Filed: August 31, 2012
    Publication date: December 27, 2012
    Applicant: INTARCIA THERAPEUTICS, INC.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • Publication number: 20120330005
    Abstract: The present invention is related to methods for lowering peroxide levels in sucrose acetate isobutyrate formulations and to composition used in and formed by such methods.
    Type: Application
    Filed: November 21, 2011
    Publication date: December 27, 2012
    Inventors: Gunjan Junnarkar, Michael A. DesJardin, John Patrick Carr